SCHEMBL24711185

SCHEMBL24711185

Cc1ccc(-c2nc3cc(C(C)C)ccc3o2)cc1NC(=S)NC(=O)c1cccc(F)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 9/20 0.60
▸ TP53 P04637 5/20 0.60
▸ MEN1 O00255 4/20 0.56
▸ KMT2A Q03164 4/20 0.56
▸ SMN1; SMN2 Q16637 3/20 0.56
▸ KDM4E B2RXH2 1/20 0.56
▸ TDP1 Q9NUW8 1/20 0.56
▸ ALDH1A1 P00352 2/20 0.55
▸ HPGD P15428 1/20 0.55
▸ DUSP1 P28562 4/20 0.51
▸ USP2 O75604 1/20 0.51
▸ LMNA P02545 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ POLB P06746 2/20 0.49
▸ HDAC3 O15379 1/20 0.48
▸ HDAC1 Q13547 1/20 0.48
▸ HDAC2 Q92769 1/20 0.48
▸ HDAC8 Q9BY41 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24711203 0.80 MAPT (0.70) MAPTTP53MEN1KMT2ASMN1; SMN2
SCHEMBL24711778 0.76 MAPT (0.68) MAPTTP53MEN1KMT2ASMN1; SMN2
SCHEMBL24711202 0.75 MAPT (0.66) MAPTTP53MEN1KMT2ASMN1; SMN2
SCHEMBL24710992 0.75 MAPT (1.00) MAPTTP53SMN1; SMN2ALDH1A1HPGD
SCHEMBL24711515 0.74 TP53 (0.80) MAPTTP53MEN1KMT2ASMN1; SMN2
SCHEMBL4361940 0.71 SMN1; SMN2 (1.00) MAPTTP53MEN1KMT2ASMN1; SMN2
SCHEMBL24710830 0.71 MAPT (0.71) MAPTTP53MEN1KMT2ASMN1; SMN2
SCHEMBL12783895 0.71 DUSP1 (0.61) MAPTTP53KDM4EALDH1A1DUSP1
SCHEMBL2739327 0.68 MAPT (0.76) MAPTTP53MEN1KMT2ASMN1; SMN2
SCHEMBL24710982 0.68 TP53 (0.75) MAPTTP53MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220395500-A1 SMALL MOLECULE ACTIVATORS OF INTERFERON REGULATORY FACTOR 3 AND METHODS OF USE THEREOF NEURALEXO, INC. 2022-12-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220395500-A1 SMALL MOLECULE ACTIVATORS OF INTERFERON REGULATORY FACTOR 3 AND METHODS OF USE THEREOF IRF3, IRF2BP2, STAT1 MAPT 4038/4885TP53 673/4885MEN1 4664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback